Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.
$0.90
As of 03/05/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.